The first step of the study has four dose levels with three patients at each level. In addition to looking at side effects, the patients are also examined for efficacy. A complete treatment consists of four injections over the course of about seven weeks. ELC-100 is injected using X-ray technology via blood vessels from the groin into the liver. The patient is evaluated one month later with combined advanced medical technology (CT, MRI, PET). At present, seven, out of a total of 12 planned patients have been treated.
Although it is too early to draw any conclusions from the study, data reported so far by Uppsala University show some promising signs of efficacy from one of the patients.